Simvastatin-loaded nano-niosomes confer cardioprotection against myocardial ischemia/reperfusion injury.
Sign Up to like & getrecommendations! Published in 2021 at "Drug delivery and translational research"
DOI: 10.1007/s13346-021-01019-z
Abstract: Although simvastatin (SIM) has been proven to be a powerful agent against myocardial ischemia/reperfusion (MI/R) injury, poor water solubility, short half-life, and low bioavailability have made it futile while using conventional drug delivery system. Hence,… read more here.
Keywords: loaded nano; myocardial ischemia; drug; ischemia reperfusion ... See more keywords